Innovative Hydrogel Technique Extends Longevity of Human Lymph Node Cultures for Improved Immune Research
A novel hydrogel-based method enhances the longevity and functionality of human lymph node tissue outside the body, improving immune response studies and personalized medicine development.
Researchers at the College of Design and Engineering (CDE) at the National University of Singapore (NUS) in collaboration with the National Cancer Center Singapore have developed a groundbreaking method to maintain human lymph node tissue alive and functional outside the body for several days. This advancement allows scientists to observe immune responses in real-time, providing a more accurate understanding of how the human immune system reacts to infections, vaccines, and cancer, without relying solely on traditional preclinical models or simplified laboratory setups.
The new approach involves embedding thin slices of lymph node tissues into a specially designed hyaluronan-based hydrogel scaffold. This hydrogel, previously utilized to preserve tumor slices, acts as a supportive matrix that mimics the body's natural environment, maintaining the tissue's size, structure, and vital functions for a longer period. In experiments, the tissue responded appropriately to exposure to cancer cells and COVID-19 mRNA vaccines, activating immune signaling pathways and producing antibodies, demonstrating that the preserved tissue remained immunologically active.
One notable finding was an immune response observed prior to vaccine exposure, indicating the model's capability to reflect individual immune history, such as prior infection. This platform offers a promising tool for studying immune dynamics and developing personalized treatments.
The current model supports tissue viability for roughly a week, but scientists are working to extend this timeframe and incorporate features such as lymph flow. Future applications could include screening vaccines and immunotherapies for cancer and infectious diseases, providing a faster, more relevant alternative to animal testing.
This innovation marks a significant step toward creating more predictive human immune system models, paving the way for more effective and personalized therapies in the future.
Source: MedicalXpress
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Early Mitochondrial Dysfunction and Myelin Loss Key Factors in Multiple Sclerosis Brain Damage
New research sheds light on how early mitochondrial impairment and myelin loss contribute to cerebellar damage in multiple sclerosis, offering hope for targeted therapies to protect brain health.
Wildfire Fine Particles May Cause Underestimated Mortality Risks by 93%
A groundbreaking study reveals that mortality linked to wildfire PM2.5 particles may be underestimated by up to 93%, emphasizing the significant health risks of wildfire smoke in a changing climate.
Innovative Enzyme Inhibitor Approach Turns Neuroblastoma Cells into Healthy Neurons in Mice
A novel enzyme inhibition approach has shown promise in converting neuroblastoma cancer cells into healthy neurons in mice, potentially leading to improved treatments for childhood neuroblastoma.
Innovative Magnetically-Guided Therapy for Personalized Brain Tumor Treatment
A novel magnetically driven biohybrid hydrogel fiber approach enables precise, minimally invasive delivery of chemotherapy to brain tumors, promising safer and more effective treatments.